# Vaginal DHEA for Women After Breast Cancer

> **NCT01724242** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Hadassah Medical Organization**

## Conditions studied

- Vaginal Dryness
- Breast Cancer
- Urinary Incontinence
- Quality of Life
- Sexual Satisfaction

## Interventions

- **DRUG:** Vaginal DHEA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01724242
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-02
- **Primary completion:** 2014-01
- **Final completion:** 2014-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Inability to recruit patients
- **Last updated:** 2017-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01724242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01724242, "Vaginal DHEA for Women After Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01724242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*